Dipl.-Biol. Siegfried J.W. Ruppert
U.S. Rechtsanwalt | U.S. Patentanwalt
U.S. Patente Für Mandanten
Im Rahmen seiner Tätigkeit als Patentagent und Patentanwalt bei namhaften U.S. Kanzleien hat Dr. Ruppert in Bereichen der Biowissenschaften und UV-Technologien sowie anderen wissenschaftlichen Gebieten für institutionelle Mandanten, U.S. Start-Up Unternehmen, und für die U.S. Regierung (National Institutes of Health) an verschiedensten Patenten gearbeitet. Hier finden Sie eine repräsentative Auflistung von U.S. Patenten, an denen Dr. Ruppert gearbeitet hat:
- U.S. Patent Nr. 10,184,933; Titel: “Compositions, sytems and methods for gene expression noise drug screening and uses thereof”
- U.S. Patent Nr. 10,155,041; Titel: “Bacterial phospholipase inhibitors as modulators of colonic bacterial flora”
- U.S. Patent Nr. 10,046,073; Titel: “Portable UV devices, systems and methods of use and manufacturing”
- U.S. Patent Nr. 9,956,260; Titel: “Treatment of HIV-1 Infection and AIDS”
- U.S. Patent Nr. 9,707,306; Titel: “UV sterilization of containers”
- U.S. Patent Nr. 9,687,575; Titel: “UV devices, systems and methods for UV sterilization”
- U.S. Patent Nr. 9,682,161; Titel: “Compositions and methods for UV sterilization”
- U.S. Patent Nr. 9,598,456; Titel: “Modified cytosine polynucleotide oligomers and methods”
- U.S. Patent Nr. 9,598,455; Titel: “Modified thymine polynucleotide oligomers and methods”
- U.S. Patent Nr. 9,387,268; Titel: “Compositions and methods for UV sterilization”
- U.S. Patent No. 9,352,010; Titel: “Treatment of HIV-1 Infection and AIDS”
- U.S. Patent Nr. 9,328,391; Titel: “Cloning and expression of HIV-1 DNA”
- U.S. Patent Nr. 9,321,730; Titel: “Method of making and administering quinoline derivatives as anti-cancer agents”
- U.S. Patent Nr. 9,309,574; Titel: “Molecular cloning of HIV-1 from immortalized cell lines”
- U.S. Patent Nr. 9,138,669; Titel: “Multilayer nanofiber filter”
- U.S. Patent Nr. 9,089,288; Titel: “Apparatus and method for non-invasive diabetic retinopathy detection and monitoring”
- U.S. Patent Nr. 9,044,521; Titel: “UV sterilization of containers”
- U.S. Patent Nr. 9,017,266; Titel: “Automated testing for palpating diabetic foot patient”
- U.S. Patent Nr. 8,993,065; Titel: “Substrate coating with aqueous-based multifunctional core shell particles”
- U.S. Patent Nr. 8,916,583; Titel: “Therapeutic compositions for intranasal administration of Zolpidem”
- U.S. Patent Nr. 8,901,292; Titel: “Method of mass production of tetrakis(p-nitrophenyl)-porphyrins”
- U.S. Patent Nr. 8,871,159; Titel: “Preparation of cells, cell aggregates and tissue fragments”
- U.S. Patent Nr. 8,785,609; Titel: Cloning and expression of HTLV-III [HIV-1] DNA”
- U.S. Patent Nr. 8,709,732; Titel: “Biomarkers of gastric cancer and uses thereof”
- U.S. Patent Nr. 8,669,354; Titel: “Removal of endotoxin using amphiphilic core-shell nanosorbents”
- U.S. Patent Nr. 8,544,252; Titel: “Method and apparatus for reducing residual torque and neps in singles ring yarns”
- U.S. Patent Nr. 8,523,971; Titel: “Multilayer nanofiber filters”
- U.S. Patent Nr. 8,399,029; Titel: “Influenza prevention and treatment compositions”
- U.S. Patent Nr. 8,349,299; Titel: “Conditioning agent and a method for making hair having a shape memory effect”
- U.S. Patent Nr. 8,344,007; Titel: “Water-soluble polymer-based canthararimides as potentially selective anti-tumor agents”
- U.S. Patent Nr. 8,338,180; Titel: “Methods for treating lentivirus infections”
- U.S. Patent Nr. 8,329,425; Titel: “Method and system for detection of chloramphenicol”
- U.S. Patent Nr. 8,318,922; Titel: “Treatment and prevention of hyperproliferative conditions in humans and antisense oligonucleotide inhibition of human replication-initiation proteins”
- U.S. Patent Nr. 7,993,647; Titel: “Monoclonal antibodies to HIV-1 and methods of using same”
- U.S. Patent Nr. 7,815,916; Titel: “Cloning and expression of HTLV-III [HIV-1] DNA”
- U.S. Patent Nr. 7,754,861; Titel: “Method for purifying proteins”
- U.S. Patent Nr. 7,723,021; Titel: “Methods for treating lentivirus infections”
- U.S. Patent Nr. 7,645,449; Titel: “Sensitizing cells for apoptosis by selectively blocking cytokines”
- U.S. Patent Nr. 6,927,028; Titel: “Noninvasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA”
Zusätzlich hat Dr. Ruppert in Kooperation mit ausländischen Anwaltskanzleien, u.a., in Europa, China, Japan, Canada, und Australien, an internationale Patenten für seine Mandanten gearbeitet.
